» Articles » PMID: 32967234

Sensing Through Non-Sensing Ocular Ion Channels

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Sep 24
PMID 32967234
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Ion channels are membrane-spanning integral proteins expressed in multiple organs, including the eye. In the eye, ion channels are involved in various physiological processes, like signal transmission and visual processing. A wide range of mutations have been reported in the corresponding genes and their interacting subunit coding genes, which contribute significantly to an array of blindness, termed ocular channelopathies. These mutations result in either a loss- or gain-of channel functions affecting the structure, assembly, trafficking, and localization of channel proteins. A dominant-negative effect is caused in a few channels formed by the assembly of several subunits that exist as homo- or heteromeric proteins. Here, we review the role of different mutations in switching a "sensing" ion channel to "non-sensing," leading to ocular channelopathies like Leber's congenital amaurosis 16 (LCA16), cone dystrophy, congenital stationary night blindness (CSNB), achromatopsia, bestrophinopathies, retinitis pigmentosa, etc. We also discuss the various in vitro and in vivo disease models available to investigate the impact of mutations on channel properties, to dissect the disease mechanism, and understand the pathophysiology. Innovating the potential pharmacological and therapeutic approaches and their efficient delivery to the eye for reversing a "non-sensing" channel to "sensing" would be life-changing.

Citing Articles

Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy.

Kabra M, Shahi P, Wang Y, Sinha D, Spillane A, Newby G J Clin Invest. 2023; 133(19).

PMID: 37561581 PMC: 10541187. DOI: 10.1172/JCI171356.


Molecular mechanism of hyperactivation conferred by a truncation of TRPA1.

Bali A, Schaefer S, Trier I, Zhang A, Kabeche L, Paulsen C Nat Commun. 2023; 14(1):2867.

PMID: 37208332 PMC: 10199097. DOI: 10.1038/s41467-023-38542-1.


Ion channels in dry eye disease.

Ashok N, Khamar P, DSouza S, Gijs M, Ghosh A, Sethu S Indian J Ophthalmol. 2023; 71(4):1215-1226.

PMID: 37026252 PMC: 10276728. DOI: 10.4103/IJO.IJO_3020_22.


V-ATPase Regulates Retinal Progenitor Cell Proliferation During Eye Regrowth in .

Kha C, Nava I, Tseng K J Ocul Pharmacol Ther. 2023; 39(8):499-508.

PMID: 36867156 PMC: 10616942. DOI: 10.1089/jop.2022.0085.


Inward rectifier potassium (Kir) channels in the retina: living our vision.

Beverley K, Pattnaik B Am J Physiol Cell Physiol. 2022; 323(3):C772-C782.

PMID: 35912989 PMC: 9448332. DOI: 10.1152/ajpcell.00112.2022.


References
1.
Wissinger B, Dangel S, Jagle H, Hansen L, Baumann B, Rudolph G . Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2. Invest Ophthalmol Vis Sci. 2008; 49(2):751-7. DOI: 10.1167/iovs.07-0471. View

2.
Guziewicz K, Slavik J, Lindauer S, Aguirre G, Zangerl B . Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies. Invest Ophthalmol Vis Sci. 2011; 52(7):4497-505. PMC: 3175949. DOI: 10.1167/iovs.10-6385. View

3.
Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S . Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009; 326(5959):1509-12. DOI: 10.1126/science.1178811. View

4.
Vincent A, Robson A, Holder G . Pathognomonic (diagnostic) ERGs. A review and update. Retina. 2012; 33(1):5-12. DOI: 10.1097/IAE.0b013e31827e2306. View

5.
Milenkovic A, Milenkovic V, Wetzel C, Weber B . BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes. Hum Mol Genet. 2018; 27(9):1630-1641. PMC: 5905664. DOI: 10.1093/hmg/ddy070. View